Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

[Image from Jp Valery on Unsplash]

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more.

Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired.

Here are the 10 biggest mergers and acquisitions in medtech in 2021:


Read more
  • 0

AdaptHealth closes $1.1B AeroCare deal

AdaptHealth this week said it has closed its acquisition of AeroCare Holdings for approximately $1.1 billion in cash and 31 million shares of AdaptHealth common stock.

Through the deal, the combined company will operate under the name AdaptHealth, and AdaptHealth CEO Luke McGee and AeroCare CEO Steve Griggs will serve as co-CEOs for the new company. Josh Parnes will continue to serve as president and AdaptHealth will expand its board of directors to 11 directors.

AeroCare develops technology-enabled respiratory and home medical equipment distribution platforms in the U.S. It makes direct-to-patient equipment and services like CPAP and BiPAP machines, oxygen concentrators, home ventilators and other durable medical equipment products.

The acquisition will enhance AdaptHealth’s scare and geographic reach with the combined company serving nearly 3 million patients from over 500 locations in 46 states.

Read more
  • 0

AdaptHealth prices $124m upsized offering

AdaptHealth (NSDQ:AHCO) announced today that it upsized and priced an underwritten offering of common stock at approximately $124 million.

Plymouth Meeting, Pa.-based AdaptHealth is offering 8 million shares of its Class A common stock at $15.50 per share. The maker of home medical equipment, supplies and related services had previously set the offering at 6.5 million shares of common stock.

Before deducting underwriting discounts and commissions and estimated offering expenses, AdaptHealth expects to pull in approximately $124 million. Additionally, it granted underwriters a 30-day option to purchase up to 1.2 million additional shares of Class A common stock.

AdaptHealth expects the offering to close on July 6, subject to customary closing conditions. It intends to use the net proceeds for general corporate purposes, including acquisitions and other business opportunities, along with capital expenditures and working capital.

Jefferies, Deutsche …

Read more
  • 0